Sep 1, 2026 09:07AM
Aug 31, 2026 06:51AM
Aug 31, 2026 05:02AM
Aug 25, 2026 04:11AM
Aug 3, 2026 04:26PM
Jul 22, 2026 04:13AM
Jul 8, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
Jul 6, 2026 04:52AM
Jun 12, 2026 04:11AM
Jun 11, 2026 04:23AM
May 27, 2026 05:45AM
May 12, 2026 09:58AM
May 5, 2026 05:12AM
Mar 17, 2026 07:12AM CRISPR Therapeutics (CRSP) PT Raised to $110 at Piper Sandler
Feb 12, 2026 05:17PM
Jan 30, 2026 05:37AM
Jan 12, 2026 08:37AM
Dec 22, 2025 08:30AM
Dec 21, 2025 04:00AM
Dec 8, 2025 04:20AM
Dec 4, 2025 10:40AM CRISPR Therapeutics (CRSP) Ticks Higher on Takeover Speculation
Nov 17, 2025 11:13AM
Nov 17, 2025 10:59AM
Nov 11, 2025 04:45AM
Nov 11, 2025 04:24AM
Nov 11, 2025 04:13AM
Nov 11, 2025 04:03AM
Nov 10, 2025 03:25PM CRISPR Therapeutics (CRSP) PT Lowered to $50 at Clear Street
Nov 10, 2025 08:12AM
Oct 31, 2025 09:54AM
Oct 27, 2025 07:59AM
Oct 24, 2025 08:29AM
Oct 13, 2025 04:27AM
Oct 10, 2025 08:00AM
Sep 23, 2025 12:35PM BMO Capital on CRISPR Therapeutics (CRSP): 'We Continue to Highlight the Large Oppty of FXI Space'
Sep 23, 2025 06:36AM
Sep 18, 2025 03:23AM
Aug 15, 2025 12:41PM
Aug 7, 2025 07:18AM
Aug 5, 2025 06:02AM
Aug 4, 2025 04:51PM
Jun 27, 2025 10:58AM CRISPR Therapeutics (CRSP) 30-day option implied volatility flat
Jun 27, 2025 06:49AM
Jun 27, 2025 04:40AM
Jun 26, 2025 04:15PM
Jun 26, 2025 02:08PM
Jun 26, 2025 11:00AM
Jun 26, 2025 10:34AM
Jun 26, 2025 10:32AM Barclays Reiterates Equalweight Rating on CRISPR Therapeutics (CRSP)
Jun 26, 2025 10:31AM

443,996 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All